Lineage Cell Therapeutics (LCTX) Shares Issued: 2010-2025
Historic Shares Issued for Lineage Cell Therapeutics (LCTX) over the last 10 years, with Sep 2025 value amounting to $487,000.
- Lineage Cell Therapeutics' Shares Issued rose 4770.00% to $487,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $716,000, marking a year-over-year increase of 111.35%. This contributed to the annual value of $229,000 for FY2024, which is 160.23% up from last year.
- Latest data reveals that Lineage Cell Therapeutics reported Shares Issued of $487,000 as of Q3 2025, which was up 4,770.00% from $10,000 recorded in Q3 2024.
- Lineage Cell Therapeutics' 5-year Shares Issued high stood at $33.1 million for Q2 2021, and its period low was -$6.5 million during Q4 2023.
- Over the past 3 years, Lineage Cell Therapeutics' median Shares Issued value was $109,500 (recorded in 2024), while the average stood at $108,250.
- Its Shares Issued has fluctuated over the past 5 years, first plummeted by 99.97% in 2022, then soared by 64,344.44% in 2023.
- Lineage Cell Therapeutics' Shares Issued (Quarterly) stood at $124,000 in 2021, then tumbled by 79.41% to $603,000 in 2022, then soared by 38.64% to -$6.5 million in 2023, then crashed by 98.80% to $10,000 in 2024, then spiked by 4,770.00% to $487,000 in 2025.
- Its Shares Issued stands at $487,000 for Q3 2025, versus $10,000 for Q3 2024 and $87,000 for Q2 2024.